What are the Benefits of Axonics Therapy?
- Safely delivers therapy with a miniaturized implant
- Is designed to provide therapy for at least 15 years
- Is MRI compatible, allowing you to undergo a full-body MRI
- Clinically proven to provide symptom relief*
How Does Axonics Therapy Work?
The Evaluation Step: To see if Axonics Therapy is right for you, you will undergo a short period of therapy using a temporary system. The evaluation period allows you to experience the level of symptom relief the therapy may provide before you commit to long-term therapy.
Long-term Therapy: If you and your doctor determine that Axonics Therapy is right for you, you will have an outpatient procedure where the miniaturized Axonics implant is placed just beneath the skin in the upper part of your buttock.
What Is Sacral Neuromodulation?
Axonics Sacral Neuromodulation Therapy provides gentle stimulation to the nerves that control the bladder and bowel. The stimulation can restore normal communication between the brain and the bladder and bowel, which can result in an improvement of your symptoms, whether you are suffering from overactive bladder, bowel incontinence, or urinary retention.
Patient Testimonials: Clinically Proven, Patient Approved
In a clinical study of patients with urinary urgency incontinence (after 6 months of therapy),
- 93% of patients were satisfied with their therapy*
- 90% of patients experienced a ≥50% reduction in UUI symptoms*
- <2% of patients reported discomfort at the implant site
What to hear from an actual patient about their experience with the Axonics Therapy? View the videos below!
Who is a Good Candidate for Axonics Therapy?
Axonics Therapy is an approved treatment for patients suffering with:
What is Axonics Therapy Not Appropriate For?
- Stress incontinence
- Treating urinary symptoms caused by mechanical obstructions, such as benign prostatic hypertrophy, cancer, or urethral stricture
- Patients who have not demonstrated an appropriate response to an external trial
- Patient with limited cognitive function, which may make it difficult to manage their therapy
- Pregnant women, the unborn fetus, and during delivery
- Pediatric patients (under the age of 18 years for FI and under the age of 16 years for OAB and UR)
- Patients with neurological disease origins, such as multiple sclerosis or diabetes